Recurrence and variability of germline EPCAM deletions in Lynch syndrome
- 18 January 2011
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 32 (4) , 407-414
Abstract
Recently, we identified 3′ end deletions in the EPCAM gene as a novel cause of Lynch syndrome. These truncating EPCAM deletions cause allele‐specific epigenetic silencing of the neighboring DNA mismatch repair gene MSH2 in tissues expressing EPCAM. Here we screened a cohort of unexplained Lynch‐like families for the presence of EPCAM deletions. We identified 27 novel independent MSH2‐deficient families from multiple geographical origins with varying deletions all encompassing the 3′ end of EPCAM, but leaving the MSH2 gene intact. Within The Netherlands and Germany, EPCAM deletions appeared to represent at least 2.8% and 1.1% of the confirmed Lynch syndrome families, respectively. MSH2 promoter methylation was observed in epithelial tissues of all deletion carriers tested, thus confirming silencing of MSH2 as the causative defect. In a total of 45 families, 19 different deletions were found, all including the last two exons and the transcription termination signal of EPCAM. All deletions appeared to originate from Alu‐repeat mediated recombination events. In 17 cases regions of microhomology around the breakpoints were found, suggesting nonallelic homologous recombination as the most likely mechanism. We conclude that 3′ end EPCAM deletions are a recurrent cause of Lynch syndrome, which should be implemented in routine Lynch syndrome diagnostics. Hum Mutat 32:1–8, 2011.Keywords
Funding Information
- The Dutch Cancer Society (2009-4335 (to M.J.L., R.P.K., and N.H.))
- The Netherlands Organization for Health Research and Development (ZonMW 917-10-358 (to R.P.K.), ZonMW 916-86-016 (to L.E.L.M.V.))
- The Sacha Swarttouw-Hijmans Foundation
- The Deutsche Krebshilfe (Familial Colorectal Cancer 70-3032)
This publication has 32 references indexed in Scilit:
- EPCAM Germ Line Deletions as Causes of Lynch Syndrome in Spanish PatientsThe Journal of Molecular Diagnostics, 2010
- Epimutations and cancer predisposition: importance and mechanismsCurrent Opinion in Genetics & Development, 2010
- Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cellsNucleic Acids Research, 2009
- Alu-Alurecombination underlies the vast majority of largeVHLgermline deletions: Molecular characterization and genotype-phenotype correlations in VHL patientsHuman Mutation, 2009
- Transcription is required for establishment of germline methylation marks at imprinted genesGenes & Development, 2009
- Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancerNature Genetics, 2006
- Identification and Survival of Carriers of Mutations in DNA Mismatch-Repair Genes in Colon CancerNew England Journal of Medicine, 2006
- Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)New England Journal of Medicine, 2005
- Alu repeats and human genomic diversityNature Reviews Genetics, 2002
- Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the DiseaseNew England Journal of Medicine, 1998